Part D/Prescription Drugs – Page 149

Wednesday, September 16, 2026

Latest:

Health Care Finance Part D/Prescription Drugs

Infusion Treatments For Low Iron Can Deplete Patients’ Wallets

(By Shefali Luthra for Kaiser Health News) Shannon Wood Rothenberg walked into her annual physical feeling fine. But more than

(By Barclay E. Berdan, Scott Reiner, and Terry Shaw for ST A T) D rug shortages are a major challenge

(By Phil Galewitz for Kaiser Health News) A year after calling proposals allowing Americans to import cheaper drugs from Canada

In a new report from the Government Accountability Office found the Medicare Plan Finder website is difficult to navigate and

According to the California attorney general’s office, two pharmaceutical companies will pay the state of California a total of nearly

(By Emmarie Huetteman for Kaiser Health News) The fight between policymakers intent on lowering prescription drug prices and the drugmakers

(By Blake Farmer, Nashville Public Radio for Kaiser Health News) In a former church parsonage in Grundy County, Tenn., Karen

(By Alia Paavola for Becker’s Hospital Review ) The FDA has approved Pfizer’s biosimilar to Rituxan, a treatment for some

(By Emmarie Huetteman for Kaiser Health News) When Washington returned from its winter holiday break in January, it seemed everyone

(By Alia Paavola for Becker’s Hospital Review) The FDA has approved several new generics of Lyrica, a brand-name drug manufactured